Oxygen Double Bonded And Nitrogen Bonded Directly To The Same Carbon Patents (Class 536/53)
-
Publication number: 20020169114Abstract: The present invention provides stable compounds prepared from boronic acid and lyophilized compounds thereof of the formula (1): 1Type: ApplicationFiled: January 25, 2002Publication date: November 14, 2002Applicant: The United States of America, Represented by The Secretary, Department of Health and Human ServicesInventor: Shanker Lal Gupta
-
Publication number: 20020164749Abstract: A bacterial &agr;1,3-fucosyltransferase gene and deduced amino acid sequence is provided. The gene is useful for preparing &agr;1,3-fucosyltransferase polypeptide, and active fragment thereof, which can be used in the production of oligosaccharides such as Lewis X, Lewis Y, and siayl Lewis X, which are structurally similar to certain tumor-associated carbohy-drate antigens found in mammals. These product glycoconjugates also have research and diagnostic utility in the development of assays to detect mammalian tumors. In addition the polypeptide of the invention can be used to develop diagnostic and research assays to determine the presence of H. pylon in human specimens.Type: ApplicationFiled: April 9, 2002Publication date: November 7, 2002Applicant: The Governors of the University of Alberta, a Canada corporationInventors: Diane E. Taylor, Zhongming Ge
-
Publication number: 20020160460Abstract: This invention provides methods for practical in vitro sialylation of glycoproteins, including recombinantly produced glycoproteins. The methods are useful for large-scale modification of sialylation patterns.Type: ApplicationFiled: February 21, 2002Publication date: October 31, 2002Applicant: Neose Technologies, Inc.Inventors: James C. Paulson, Robert J. Bayer, Eric Sjoberg
-
Publication number: 20020161221Abstract: A compound of formula (I) below, which exhibits excellent macrophage activity inhibitory action, is useful for the treatment or prophylaxis of inflammatory disorders, autoimmune diseases or septicemia. In a preferred embodiment, R1 and R3 each represents a C1-C20 alkanoyl group which may optionally be substituted with one or more substituent groups selected from substituent group A, R2 and R4 each represents a C1-C20 alkyl group which may optionally be substituted with one or more substituent groups selected from substituent group A, R5 is a hydrogen atom, a halogen atom, a hydroxy group, or a C1-C6 alkoxy group, and substituent group A is a halogen atom, a hydroxy group, an oxo group, a C1-C20 alkoxy group, or a C1-C20 alkanoyloxy group.Type: ApplicationFiled: August 9, 2001Publication date: October 31, 2002Applicant: SANKYO COMPANY, LIMITEDInventors: Yukiko Kazama, Masao Shiozaki, Shinichi Kurakata, Saori Kanai
-
Publication number: 20020160416Abstract: A member of the tumor necrosis factor family and its receptor are described. This member is primarily expressed in B cells and its expression correlates to increases in the number of B cells and immunoglobulins produced. The natural, preferred human ortholog is here called AGP-3R. The protein is a type III transmembrane protein and has an amino terminal extracellular domain, a transmembrane domain, and a carboxy terminal intracellular domain. AGP-3R-related proteins of the invention may be membrane-associated or in soluble form, recombinantly produced or isolated after natural production. The invention provides for nucleic acids encoding such AGP-3R-related proteins, vectors and host cells expressing the polypeptides, and methods for producing recombinant proteins. Antibodies or fragments thereof that specifically bind the proteins are also provided.Type: ApplicationFiled: February 12, 2001Publication date: October 31, 2002Inventors: William J. Boyle, Hailing Hsu
-
Publication number: 20020148791Abstract: The invention provides methods for purifying carbohydrates, including oligosaccharides, nucleotide sugars, and related compounds, by use of ultrafiltration, nanofiltration and/or reverse osmosis. The carbohydrates are purified away from undesired contaminants such as compounds present in reaction mixtures following enzymatic synthesis or degradation of oligosaccharides.Type: ApplicationFiled: March 22, 2002Publication date: October 17, 2002Applicant: Neose TechnologiesInventor: Shawn DeFrees
-
Publication number: 20020150572Abstract: This invention provides methods of treating psoriasis which entail eliciting an immune response in an individual against an antigen aberrantly expressed in psoriatic tissue, such as a ganglioside, in an individual. The anti-ganglioside immune response is elicited by administration of an antigen such as a ganglioside, an anti-idiotype moiety for a ganglioside, or a polynucleotide encoding an anti-idiotype moiety. Also described is a strategy for developing additional compositions for psoriasis. The compositions elicit an immunological response against a target antigen present on psoriatic tissue, which in turn can be detected using antibody affinity-purified from the serum of the treated subject. The presence of the immunological response correlates positively with control or resolution of the psoriatic symptoms.Type: ApplicationFiled: November 20, 2001Publication date: October 17, 2002Inventors: Kenneth A. Foon, Malaya Chatterjee
-
Publication number: 20020151026Abstract: The present invention relates to an isolated or recombinant nucleic acid which encodes a mammalian hyaluronan synthase (e.g. human). The present invention also relates to a host cell comprising the nucleic acid encoding mammalian hyaluronan synthase. The present invention also relates to a method for producing a mammalian hyaluronan synthase comprising introducing into a host cell a nucleic acid construct comprising a nucleic acid which encodes a mammalian hyaluronan synthase, whereby a recombinant host cell is produced having said coding sequence operably linked to at least one expression control sequence; and maintaining the host cells produced in a suitable medium under conditions whereby the nucleic acid is expressed. The present invention also relates to an antibody or functional portion thereof which binds mammalian hyaluronan synthase.Type: ApplicationFiled: October 19, 2001Publication date: October 17, 2002Applicant: Millennium Pharmaceuticals, Inc.Inventor: Michael J. Briskin
-
Publication number: 20020146504Abstract: The present invention is directed to methods for immobilizing natural or synthetic biomolecules to surfaces comprising covalently linking the natural or synthetic biomolecule to a mono- or bi-functional polymer and covalently and/or electrostatically immobilizing the biomolecule/polymer conjugate to an unmodified or modified surface wherein the biomolecule is an oligonucleotide, a polynucleotide, a protein, a glycoprotein, a peptide or a carbohydrate that has been modified to incorporate a single or plurality of nucleophilic groups comprising an aliphatic or aromatic amino, thiol, hydrazine, thiosemicarbazide, hydrazide, thiocarbazide, carbazide, aminooxy, a derivative of 2-hydrazinopyridine or aminoxyacetic acid or a single or plurality of electrophilic groups comprising an aliphatic or aromatic aldehyde, ketone, epoxide, isocyanate, isothiocyanate, succinimidyl ester or cyanuric chloride or a linkable aromatic aldehyde or ketone and the surface has been modified to possess either neutral, cationic or anioniType: ApplicationFiled: January 15, 2002Publication date: October 10, 2002Inventor: David A. Schwartz
-
Publication number: 20020146736Abstract: The present invention pertains to luminescent dyes and methods for covalently attaching the dyes to a component or mixture of components so that the components may be detected and/or quantified by luminescence detection methods. The dyes are cyanine and cyanine-type dyes that contain or are derivatized to contain a reactive group. The reactive group is covalently reactive with amine, hydroxy and/or sulfhydryl groups on the component so that the dye can be covalently bound to the component. In addition, the dyes are preferably soluble in aqueous or other medium in which the component is contained. The components to be labeled can be either biological materials, such as antibodies, antigens, peptides, nucleotides, hormones, drugs, or non-biological materials, such as polymers, glass, or other surfaces. Any luminescent or light absorbing detecting step can be employed in the method of the invention.Type: ApplicationFiled: March 22, 2002Publication date: October 10, 2002Applicant: Carnegie Mellon UniversityInventor: Alan S. Waggoner
-
Publication number: 20020143160Abstract: 1.Type: ApplicationFiled: March 6, 2002Publication date: October 3, 2002Applicant: NOF CORPORATIONInventors: Junzo Sunamoto, Kazunari Akiyoshi, Ryuzo Hosotani, Akio Hayashi, Hiroki Fukui
-
Publication number: 20020142340Abstract: The present invention pertains to luminescent dyes and methods for covalently attaching the dyes to a component or mixture of components so that the components may be detected and/or quantified by luminescence detection methods. The dyes are cyanine and cyanine-type dyes that contain or are derivatized to contain a reactive group. The reactive group is covalently reactive with amine, hydroxy and/or sulfhydryl groups on the component so that the dye can be covalently bound to the component. In addition, the dyes are preferably soluble in aqueous or other medium in which the component is contained. The components to be labeled can be either biological materials, such as antibodies, antigens, peptides, nucleotides, hormones, drugs, or non-biological materials, such as polymers, glass, or other surfaces. Any luminescent or light absorbing detecting step can be employed in the method of the invention.Type: ApplicationFiled: March 22, 2002Publication date: October 3, 2002Applicant: Carnegie Mellon UniversityInventor: Alan S. Waggoner
-
Publication number: 20020141968Abstract: Methods of forming crosslinked hyaluronic acid anti-adhesion barriers, crosslinked hyaluronic acid anti-adhesions barriers, methods for preventing or inhibiting adhesions, and methods of promoting healing of a wound are provided. The method of forming the crosslinked hyaluronic acid anti-adhesion barrier includes freeze-drying a solution including hyaluronic acid to form a hyaluronic acid foam, which is then reacted with a crosslinking agent to form a crosslinked hyaluronic acid foam. The crosslinked hyaluronic acid foam is mixed with a solution containing hyaluronic acid to form an anti-adhesion barrier.Type: ApplicationFiled: December 28, 2001Publication date: October 3, 2002Inventor: Guanghui Zhang
-
Publication number: 20020142370Abstract: This invention provides methods for practical in vitro sialylation of glycoproteins, including recombinantly produced glycoproteins. The methods are useful for large-scale modification of sialylation patterns.Type: ApplicationFiled: February 21, 2002Publication date: October 3, 2002Applicant: Neose Technologies, Inc.Inventors: James C. Paulson, Robert J. Bayer, Eric Sjoberg
-
Publication number: 20020143171Abstract: This invention relates to a chemically modified hyaluronic acid and salts thereof, which are obtained by O-acylating, alkoxylating or crosslinking a complex consisting of hyaluronic acid or a salt thereof and a cationic compound in a nonaqueous solvent, and a process for the production thereof. The nonaqueous solvent used in the invention is preferably one or more solvents selected from the group consisting of chloroform, toluene, methylene chloride and heptane.Type: ApplicationFiled: March 28, 2002Publication date: October 3, 2002Applicant: CHISSO CORPORATIONInventors: Nobuhiko Yui, Tooru Ooya, Ikuo Sato
-
Publication number: 20020136730Abstract: A substantially pure capsular exopolysaccharide adhesin of coagulaso-negative staphylococcal strains, and a general method to prepare such adhesins, are described. Vaccines composed of such adhesins, and uses of such adhesins to produce polyclonal and mono-clonal antibodies against such adhesins, are also disclosed. The adhesins are useful in coating polymeric medical materials to prevent colonization by coagulase-negative staphylococcal strains, and as a probe in selecting desirable polymeric medical materials. Such adhesin antibodies are useful in vivo to prevent infection by noso-comial coagulase-negative staphylococcal strains, in assays for the detection of such bacteria, in assays for the estimation of such adhesins in complex mixtures, and as an affinity chromatography matrix.Type: ApplicationFiled: March 8, 2002Publication date: September 26, 2002Inventor: Gerald B. Pier
-
Publication number: 20020132254Abstract: Systems, including compositions and methods, for purifying and/or labeling proteins or other molecules of interest and/or for assaying the conformational and/or binding states of such molecules.Type: ApplicationFiled: November 30, 2001Publication date: September 19, 2002Inventor: Jesse J. Twu
-
Publication number: 20020131984Abstract: Disclosed is an H. influenzae type b polysaccharide-meningococcal outer membrane protein conjugate, pharmaceutical compositions thereof, and the use thereof to induce an immune response to H. influenzae in an animal.Type: ApplicationFiled: May 10, 2002Publication date: September 19, 2002Inventors: Milan S. Blake, Francis Michon, Peter C. Fusco, Iver Heron
-
Publication number: 20020127599Abstract: A combinatorial complex carbohydrate library is provided and including a plurality of addressable complex carbohydrate structures.Type: ApplicationFiled: May 21, 2001Publication date: September 12, 2002Applicant: Glycominds Ltd.Inventors: Avinoam Dukler, Nir Dotan
-
Publication number: 20020128381Abstract: The present invention provides a method for immobilising a polysaccharide (PS) to a solid surface, said polysaccharide having a keto-carboxy group (—C(═O)—COOH) or a ketal or hemiketal group corresponding thereto, e.g. derived from KDO (2-keto-3-deoxy-D-manno-octonic acid)), the method comprising the steps of: (a) forming a covalent bond between the carboxy group of the polysaccharide and a reporter molecule (RM), thereby forming a polysaccharide-reporter molecule conjugate (PS-RM), said reporter molecule comprising a recognition/substrate site (e.g. biotin or an anthraquinone); and (b) immobilising the polysaccharide-report molecule conjugate by forming a specific bond (e.g. by photocoupling or formation of an affinity pair) between the recognition/substrate site of said reporter molecule and a reception/reagent site of the solid surface. The present invention also provides a solid surface thus obtainable and the use of such solid surfaces for diagnostic purposes, e.g.Type: ApplicationFiled: April 25, 2002Publication date: September 12, 2002Applicant: Exiqon A/SInventors: Mogens Havsteen Jakobsen, Ulrik Boas, Eva Irene Stenbaek Jauho, Peter M. H. Heegaard
-
Publication number: 20020128214Abstract: A C-glucosyl ether lipid of the following formula: 1Type: ApplicationFiled: December 11, 2001Publication date: September 12, 2002Inventors: Robert Bittman, Gilbert Arthur, Richard W. Franck
-
Publication number: 20020122809Abstract: The present invention is directed to a method for purifying polysaccharides capable of inducing the production of high titers of opsonic antibodies that kill strains of enterococcal bacteria. In addition, the invention is directed to the antigens produced by this purification method and to vaccines which utilize such antigens.Type: ApplicationFiled: March 11, 2002Publication date: September 5, 2002Applicant: The Brigham and Women's Hospital, Inc.Inventors: Gerald B. Pier, Johannes Huebner, Ying Wang, Lawrence Madoff
-
Publication number: 20020119166Abstract: The invention relates to compositions of the capsular polysaccharide/adhesin (PS/A) of staphylococci. The PS/A may be isolated or synthesized and includes various modifications to the structure of native PS/A based on the chemical characterization of PS/A. The invention also relates to the use of the PS/A as a vaccine for inducing active immunity to infections caused by Staphylococcus aureus, S. epidermidis, other related coagulase-negative staphylococci and organisms carrying the ica (intracellular adhesin) locus, and to the use of antibodies directed to PS/A for inducing passive immunity to the same class of infections.Type: ApplicationFiled: January 26, 2001Publication date: August 29, 2002Inventors: Gerald Pier, Ying Wang, David McKenney
-
Publication number: 20020111502Abstract: This invention provides methods and compositions for enhancing transfer of an agent into a cell. The agents can include polypeptides, polynucleotides such as genes and antisense nucleic acids, and other molecules. In some embodiments, the agents are modulating agents that can modulate a cellular activity or function when introduced into the cell. The methods and compositions are useful for introducing agents into individual cells, as well as cells that are present as a tissue or organ.Type: ApplicationFiled: January 22, 2002Publication date: August 15, 2002Applicant: Canji, Inc.Inventors: Heidrun Engler, Tattanahalli L. Nagabhushan, Stephen Kenneth Youngster
-
Publication number: 20020106792Abstract: The present invention relates to a purified, easily produced poly-&bgr;-1→4-N-acetylglucosamine (p-GlcNAc) polysaccharide species. The p-GlcNAc of the invention is a polymer of high molecular weight whose constituent monosaccharide sugars are attached in a &bgr;-1→4 conformation, and which is free of proteins, and substantially free of single amino acids, and other organic and inorganic contaminants. In addition, derivatives and reformulations of p-GlcNAc are described. The present invention further relates to methods for the purification of the p-GlcNAc of the invention from microalgae, preferably diatom, starting sources. Still further, the invention relates to methods for the derivatization and reformulation of the p-GlcNAc. Additionally, the present invention relates to the uses of pure p-GlcNAc, its derivatives, and/or its reformulations.Type: ApplicationFiled: December 5, 2001Publication date: August 8, 2002Applicant: Marine Polymer Technologies, Inc.Inventors: John N. Vournakis, Sergio Finkielsztein, Ernest R. Pariser, Mike Helton
-
Publication number: 20020103378Abstract: The present invention includes a method for carbamoylating an alcohol with sodium cyanate in the presence of methanesulfonic acid. The reaction can be conducted under anhydrous conditions. This method is suitable for carbamoylating a molecule including both an alcohol moiety and a basic moiety and/or a molecule including both an alcohol moiety and a sulfenyl moiety, such as the sulfenyl alcohol precursor of the antiviral agent Capravirine.Type: ApplicationFiled: January 25, 2002Publication date: August 1, 2002Inventor: James E. Ellis
-
Publication number: 20020098579Abstract: The present invention relates to a purified, easily produced poly-&bgr;-1→4-N-acetylglucosamine (p-GlcNAc) polysaccharide species. The p-GlcNAc of the invention is a polymer of high molecular weight whose constituent monosaccharide sugars are attached in a &bgr;-1→4 conformation, and which is free of proteins, and substantially free of single amino acids, and other organic and inorganic contaminants. In addition, derivatives and reformulations of p-GlcNAc are described. The present invention further relates to methods for the purification of the p-GlcNAc of the invention from microalgae, preferably diatom, starting sources. Still further, the invention relates to methods for the derivatization and reformulation of the p-GlcNAc. Additionally, the present invention relates to the uses of pure p-GlcNAc, its derivatives, and/or its reformulations.Type: ApplicationFiled: December 5, 2001Publication date: July 25, 2002Applicant: Marine Polymer Technologies, Inc.Inventors: John N. Vournakis, Sergio Finkielsztein, Ernest R. Pariser, Mike Helton
-
Publication number: 20020098244Abstract: A gel made of hyaluronic acid alone which is hardly soluble in a neutral aqueous solution.Type: ApplicationFiled: January 17, 2002Publication date: July 25, 2002Applicant: Denki Kagaku Kogyo Kabushiki KaishaInventors: Yoshiaki Miyata, Akio Okamoto, Masatoshi Kawata, Kazuhiro Oshima, Masamichi Hashimoto, Kazuhiko Arai
-
Publication number: 20020094541Abstract: A combinatorial complex carbohydrate library is provided and including a plurality of addressable complex carbohydrate structures.Type: ApplicationFiled: May 21, 2001Publication date: July 18, 2002Inventors: Avinoam Dukler, Nir Dotan
-
Publication number: 20020094950Abstract: A rigidly spaced, cyclodextrin dimers having a preselected breaking point within the spacer sequence so as to controllably release the active pharmaceutically active substance only after it reaches the desired treatment site is described. These preselected breaking points are stable in blood but are cleavable within cells. In preferred embodiments, the cyclodextrin-pharmaceutically active substance complex is targeted to specific sites via incorporation of specific antibodies for the targeted sites, typically by complexing a biotin-avidin system to specific antibodies which thereby targets the complex to a specific site. Once at the site as the complex is taken up into the cell the preselected break point is cleaved and the encapsulated pharmaceutically active substance becomes available for action within the targeted cell.Type: ApplicationFiled: January 12, 2001Publication date: July 18, 2002Inventors: Jorg G. Moser, Ralph Hoffmann
-
Patent number: 6420552Abstract: The present invention provides improved method of preparing a 4-O-alkyl chromogenic ketoside of N-acetylneuraminic acid (Neu5Ac) and a 7-O-alkyl chromogenic ketoside of N-acetylneuraminic acid (Neu5Ac) for use in the selective detection of various influenza viruses and parainfluenza viruses. The ketosides are substrates that are selectively cleaved by a neuraminidase on the virus to be detected, but not by neuraminidases found on other viruses or on bacteria, or on the cells of the host. The syntheses are efficient and provide large quantities of the ketosides for commercial development. The synthesis includes a step of alkylating the 4- or 7-hydroxyl groups of a protected alkyl ester alkyl ketoside derivative of Neu5Ac by processes that include contacting the derivative with a composition comprising an alkyl halide to form a 4- or a 7-O-alkyl protected alkyl ester alkyl ketoside derivative of Neu5Ac.Type: GrantFiled: August 29, 2000Date of Patent: July 16, 2002Assignee: Zymetx, Inc.Inventors: Om Srivastava, Geeta Srivastava, Minghui Du, Ole Hingsgaul, David R. Bundle
-
Publication number: 20020091251Abstract: The present invention relates to a process for the production of cross-linked hyaluronic acid (HA) derivatives, in particular multiple, e.g. double cross-linked hyaluronic acid derivatives. The invention also provides novel cross-linked HA derivatives, products containing them and their uses in medical and pharmaceutical and cosmetic applications.Type: ApplicationFiled: August 2, 2001Publication date: July 11, 2002Applicant: Vitrolife UK LimitedInventor: Xiaobin Zhao
-
Publication number: 20020090370Abstract: The present invention provides a porcine antigen that binds to human xenoreactive antibodies. The porcine antigen differs from the known porcine xenoantigens in that the antigen does not include an &agr;Gal epitope. The present invention also provides methods to purify the porcine antigen of the invention, as well as agents that bind to the antigen. The antigen may be used to generate antibodies against the antigen. The antigen is useful for detecting the presence of human xenoreactive antibodies against the antigen in blood and blood compositions, and antibodies against the antigen may be used to detect the presence of the antigen in samples. The invention also provides methods and pharmaceutical compositions for reducing a host rejection response to a porcine xenograft. Finally, a method to treat human blood or blood-derived compositions to reduce the level of human xenoantibodies is disclosed.Type: ApplicationFiled: January 2, 2001Publication date: July 11, 2002Inventor: Alex Zhu
-
Publication number: 20020082221Abstract: Novel nitric-oxide releasing lipid molecules are provided which comprise a lipid molecule selected from (a) phosphoglycerides, (b) lipids having a sphingosine base as a backbone, (c) monoacylglyerols, (d) diacylglycerols, (e) glycosylacylglycerols, and (f) sterol compounds of the formula: 1Type: ApplicationFiled: December 21, 2000Publication date: June 27, 2002Applicant: Scimed Life Systems, Inc.Inventors: Robert A. Herrmann, Wendy Naimark
-
Publication number: 20020077472Abstract: In order to provide the anti-retrovirus active compound with low anti-coagulant action and low cytotoxicity, compounds comprising glycoside or the salt thereof wherein lipid is linked to position 2 of sialic acid having all hydroxyl groups at positions 4, 7, 8 and 9 completely sulfated, or KDN (2-keto-3-deoxy-D-glycero-2-nononic acid) having all hydroxyl groups at positions 4, 5, 7, 8 and 9 completely sulfated are provided.Type: ApplicationFiled: October 31, 2001Publication date: June 20, 2002Applicant: Nissin Food Products Co., Ltd.Inventors: Shuji Fujita, Masaaki Numata, Kazuo Suzuki, Shigeki Nunomura, Mamoru Sugimoto, Masaki Terada
-
Publication number: 20020077456Abstract: There is disclosed a process for producing an amide compound, which process is characterized in that a compound having an amino group are reacted with a polyaminopolycarboxylic acid anhydride in the presence of the polyaminopolycarboxylic acid.Type: ApplicationFiled: October 9, 2001Publication date: June 20, 2002Inventors: Naoyuki Takano, Daisaku Nakamura
-
Publication number: 20020077304Abstract: Methods and compositions for treating or ameliorating diseases and other conditions, such as infectious diseases, autoimmune diseases and allergies are provided. The methods employ mono- and disaccharide-based compounds for selectively stimulating immune responses in animals and plants.Type: ApplicationFiled: May 18, 2001Publication date: June 20, 2002Inventors: David H. Persing, Richard Thomas Crane, Gary T. Elliott, J. Terry Ulrich, Michael J. Lacy, David A. Johnson, Jory R. Baldridge, Rong Wang
-
Patent number: 6407072Abstract: Novel N-acyl-lysogangliosides obtained from gangliosides by deacyation of the ceramide group, wherein the acyl group is derived from an aliphatic acid having from 2 to 24 carbon atoms, substituted by one or more polar groups. The N-acyl-lysogangliosides of the invention exhibit an inhibiting action on protein-kinase C activation and, thus, can be utilized in therapies for various pathologies of the nervous system.Type: GrantFiled: June 30, 1994Date of Patent: June 18, 2002Assignee: Fidia S.p.A.Inventors: Francesco Della Valle, Aurelio Romeo
-
Publication number: 20020068818Abstract: A method is provided for covalently linking carbohydrates, proteins, nucleic acids, and other biomolecules under neutral conditions, using a Diels-Alder cycloaddition reaction. In an example, activated carbon-carbon double bonds were attached to free amino sites of a carrier protein, and a conjugated diene was attached to a carbohydrate hapten. Spontaneous coupling of the carbohydrate and the protein components under very mild conditions provided glycoconjugates containing up to 37 carbohydrate hapten units per carrier protein molecule. The method is also applicable to the immobilization of biomolecules on gel or solid supports. The conjugated products are useful as immunogens and as analytical and diagnostic reagents.Type: ApplicationFiled: August 9, 2001Publication date: June 6, 2002Inventor: Vince Pozsgay
-
Patent number: 6399590Abstract: The invention concerns a novel phosphoglycolipid compound. The compound of the subject invention is 2-Deoxy-6-O-[2-deoxy-4-O-phosphono-3-O-[(R)-3-tetradecanoyloxytetradecanoyl]-2-[(R)-3-octadecanoyloxytetradecanoylamino]-&bgr;-D-glucopyranosyl]-2-[(R)-3-hexadecanoyloxytetradecanoylamino]-D-glucopyranose and pharmaceutically acceptable salts thereof. The compound is not immunoreactive, not pyrogenic, not toxic but is active in ameliorating tissue damage due to ischemia/reperfusion injury. Methods for using the subject compound to protect against reversible and irreversible damage due to ischemia/reperfusion injury are also disclosed.Type: GrantFiled: August 10, 2001Date of Patent: June 4, 2002Assignee: Corixa CorporationInventors: Gary T. Elliott, Patricia A. Weber, C. Gregory Sowell
-
Publication number: 20020058774Abstract: The present invention includes a polyol produced according to the process comprising reacting a multifunctional alcohol with a first multifunctional component to form a reaction product and reacting the reaction product with a vegetable oil to form a polyol. The present invention also relates to the material comprising the reaction product of an A-side and a B-side, wherein the A-side comprises an isocyanate and the B-side comprises the product formed by the process comprising the steps of reacting a multifunctional alcohol with a first multifunctional component to form a precursor polyol and then reacting the precursor polyol with a vegetable oil to form a vegetable based polyol with selectable functionality.Type: ApplicationFiled: August 31, 2001Publication date: May 16, 2002Inventors: Thomas M. Kurth, Richard A. Kurth, Robert B. Turner, Les P. Kreifels, Todd A. Van Thomme
-
Publication number: 20020058804Abstract: The present invention provides a compound that includes an active therapeutic agent attached to a blocking moiety that is sensitive to the catalytic action of molecules having retro-aldol and retro-Michael catalytic activity, methods for making such compounds and methods of converting such compounds to active therapeutic agents using molecules having aldolase activity.Type: ApplicationFiled: June 18, 2001Publication date: May 16, 2002Applicant: The Scripps Research InstituteInventors: Carlos F. Barbas, Doron Shabat, Christoph Rader, Benjamin List, Richard A. Lerner
-
Publication number: 20020055094Abstract: The invention provides a method of detection of influenza virus which utilises compounds able to bind specifically to the active site of influenza virus neuraminidase, and novel compounds for use in the method.Type: ApplicationFiled: April 3, 2001Publication date: May 9, 2002Inventors: Phillip A. Reece, Wen-Yang Wu, Betty Jin, Guy Y. Krippner, Keith Geoffrey Watson
-
Publication number: 20020051788Abstract: A method is provided for covalently linking carbohydrates, proteins, nucleic acids, and other biomolecules under neutral conditions, using a Diels-Alder cycloaddition reaction. In an example, activated carbon-carbon double bonds were attached to free amino sites of a carrier protein, and a conjugated diene was attached to a carbohydrate hapten. Spontaneous coupling of the carbohydrate and the protein components under very mild conditions provided glycoconjugates containing up to 37 carbohydrate hapten units per carrier protein molecule. The method is also applicable to the immobilization of biomolecules on gel or solid supports. The conjugated products are useful as immunogens and as analytical and diagnostic reagents.Type: ApplicationFiled: August 1, 2001Publication date: May 2, 2002Inventor: Vince Pozsgay
-
Publication number: 20020048588Abstract: Aminoalkyl glucosaminide phosphate (AGP) compounds that are adjuvants and immunoeffectors are described and claimed. The compounds have a 2-deoxy-2-amino glucose in glycosidic linkage with an aminoalkyl (aglycon) group. Compounds are phosphorylated at the 4 or 6 carbon on the glucosaminide ring and comprise three 3-alkanoyloxyalkanoyl residues. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Methods for using the compounds as adjuvants and immunoeffectors are also disclosed.Type: ApplicationFiled: July 12, 2001Publication date: April 25, 2002Inventors: David A. Johnson, C. Gregory Sowell
-
Publication number: 20020049314Abstract: The present invention provides novel compounds that function as immunological adjuvants when co-administered with antigens, including, antigens used as vaccines for any disease or condition amenable to vaccination. The invention also provides adjuvant formulations comprising the novel compounds of the invention and methods for immunizing humans and non-human animals.Type: ApplicationFiled: July 30, 2001Publication date: April 25, 2002Inventors: Lynn D. Hawkins, Sally T. Ishizaka, Michael Lewis, Pamela McGuiness, Jeffrey Rose
-
Publication number: 20020045586Abstract: Methods for treating diseases or conditions modulated or ameliorated by nitric oxide, particularly ischemia and reperfusion injury, are provided, using glycolipids structurally related to monophosphoryl lipid A but with notable reduction in proinflammatory and pyrogenic activity.Type: ApplicationFiled: March 14, 2001Publication date: April 18, 2002Inventors: Gary T. Elliott, David Johnson, Patricia A. Weber, C. Gregory Sowell
-
Publication number: 20020042102Abstract: A new class of synthetic glycosulfopeptides (GSPs) which have one or more sulfated tyrosine residues and a glycan linked to the peptide, the glycan preferably including a sialyl Lewisx group or a sialyl Lewisa group. In a preferred version the GSPs have an O-glycan comprising a &bgr;1,6 linkage to a GalNAc. The present invention further contemplates in vitro methods of the synthesis of these GSPs without the use of the cells and methods of their use in vivo as powerful anti-inflammatory antithrombotic, or anti-metastatic compounds. The invention also contemplates a method of synthesizing oligosaccharides by cleaving the glycan from the GSP.Type: ApplicationFiled: May 4, 2001Publication date: April 11, 2002Inventors: Richard D. Cummings, Rodger P. McEver
-
Publication number: 20020037874Abstract: The present invention id directed to novel sulphated compounds of hyaluronic acid and derivatives thereof, optionally salified, wherein the glucosamines are partially N-sulphated and partially or totally O-sulphated in position 6. The compounds of the invention have anticoagulant and antithrombotic activities and are useful in the preparation of pharmaceutical compositions and biomaterial and in the production of coatings for biomaterials compositions and biomaterials and in the production of coating for biomedical objects.Type: ApplicationFiled: October 3, 2001Publication date: March 28, 2002Applicant: FIDIA ADVANCED BIOPOLYMERSInventors: David Renier, Lanfranco Callegaro
-
Publication number: 20020038017Abstract: The present invention provides a method of synthesizing an allyl pentasaccharide having the structure: 1Type: ApplicationFiled: October 12, 2001Publication date: March 28, 2002Applicant: The Trustees of Columbia UniversityInventors: Samuel J. Danishefsky, Victor Behar, Kenneth O. Lloyd